Urinary tract infections

Current Opinion in Urology

Volumn 6, Issue 2, 1996, Pages 100-103

  Anderson, Peter A M ^a  

^a IWK Childrens Hospital   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC PROPHYLAXIS; BACTERIUM ADHERENCE; BACTERIUM PILUS; BLOOD GROUP; HOST PARASITE INTERACTION; IMMUNE RESPONSE; KIDNEY SCAR; KIDNEY TRANSPLANTATION; MOUSE; MUCOSA; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SHORT SURVEY; URINARY TRACT; URINARY TRACT INFECTION;

EID: 0029960953     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-199603000-00010     Document Type: Short Survey

References (25)

1. Mobley H, Island M, Massad G: Virulence determinants of uropathogenic Escherichia coli and Proteus mirabilis. Kidney Int 1994, 46:8129-8136. Virulence determinants of uropathogens tend to be multifactorial. This paper succinctly reviews the known and putative factors for two common bacteria.
2. Johnson J: Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 1991, 4:80-128.
3. Kisielius P, Schwan W, Armundsen S, Duncan J, Schaeffer A: In vivo expression and variation of Escherichia coli type I and P pili in the urine of adults with acute urinary tract infections. Infect Immun 1989, 57:1656-1662.
4. Reid G, Brooks H, Bacon D: In vitro attachment of Escherichia coli to human uroepithelial cells: variation in receptivity during the menstrual cycle and pregnancy. J Infect Dis 1983, 148:412-421.
5. Wold A, Thorssen M, Hull S, Svanborg-Eden C: Attachment of Escherichia coli via mannose- or Galα1-4Galβ-containing receptors to human colonic epithelial cells. Infect Immun 1988, 56:2531-2537.
6. Anderson P, Engberg I, Lidin-Janson G, Lincoln K, Hull R, Hull S, Svanborg C: Persistence of Escherichia coli bacteriuria is not determined by bacterial adherence. Infect Immun 1991, 59:2915-2921.
7. Bartkova G, Ciznar I, Lehotska V, Kernova T: Characterization of adhesion associated surface properties of uropathogenic Escherichia coli. Folia Microbiol (Praka) 1994, 39:373-377.
8. Roberts J, Marklund B, Ilver D, Haslam D, Kaack M, Baskin G, Louis M, Mollby R, Winberg J, Normark S: The gal (α1-4) gal-specific tip adhesin of Escherichia coli p-fimbriae is needed for pyelonephritis to occur in the normal urinary tract. Proc Natl Acad Sci USA 1994, 91:11889-11893.
9. Nickel J, Costerton J, McLean R, Olson M: Bacterial biofilms: influence on the pathogenesis, diagnosis, and treatment of urinary tract infections. J Antimicrob Chemother 1994, 33 (Suppl A):31-41.
10. Matsumoto T, Mizunoe Y, Sakamoto N, Tanaka M, Kumazawa J: Increased renal scarring by bacteria with mannose-sensitive pili. Urol Res 1990, 18:299-303.
11. Mizunoe Y, Matsumoto T, Haraoka M, Sakumoto M, Kubo S, Kumazawa J: Effect of pili of Serratia marcescens on superoxide production and phagocytosis of human polymorphonuclear leukocytes. J Urol 1995, 154:1227-1230. Superoxide is known to be released by phagocytes and is toxic to bothbacterial and mammalian cells. This study demonstrates that type 1 pili actively stimulate superoxide production, and this may explain why infections with bacteria that express these pili are strongly associated with renal scarring.
12. Matsumoto T, Mizunoe Y, Ogata N, Tanaka M, Kumazawa J: Role of superoxide in renal scarring following infection by mannose-sensitive piliated bacteria. Urol Res 1991, 19:229-232.
13. Roberts J, Kaack M, Baskin G: Treatment of experimental pyelonephritis in the monkey. J Urol 1990, 143:150-154.
14. Roberts J, Roth J, Domingue G, Lewis R, Kaack B, Baskin G: Immunology of pyelonephritis in the primate model (part V): effect of superoxide dismutase. J Urol 1982, 129:1394-1400.
15. Haraoka M, Matsumoto T, Takahashi K, Kubo S, Tanaka M, Kumazawa J: Suppression of renal scarring by prednisolone combined with ciprofloxacin in ascending pyelonephritis in rats. J Urol 1994, 151:1078-1080.
16. Martinell J, Claesson I, Lidin-Janson G, Jodal U: Urinary infection, reflux, and renal scarring in females continuously followed for 13-38 years. Pediatr Nephrol 1995, 9:131-136. This study provides a rare opportunity to observe the long-term outcomes of reflux in 87 females with a history of childhood UTI. The findings are concerning in that these women remained at high risk for pyelonephritic recurrences well into adulthood, especially those who were known to have renal scars.
17. Plos K, Connell H, Jodal U, Britt-Inger M, Marild S, Wettergren B, Svanborg C: Intestinal carriage of P fimbriated Escherichia coli and the susceptibility to urinary tract infection in young children. J Infect Dis 1995, 171:625-631. Persons who develop UTI are more likely to carry P fimbriated strains of E coli in the large intestine and these bacteria will cause UTI more often than non-P fimbriated strains in the faecal flora of the same host. This implies that P fimbriae confer a colonization advantage to the organism which increases its virulence.
18. Lomberg H, Hanson L, Jacobson B, Jodal U, Leffler H, Svanborg-Eden C: Correlation of P blood group phenotype, vesicoureteral reflux and bacterial attachment in patients with recurrent pyelonephritis. N Engl J Med 1983, 308:1189-1192.
19. Navas E, Venegas M, Duncan J, Anderson B, Kanerva C, Chimel C, Schaeffer A: Blood group antigen expression on vaginal cells and mucus in women with and without a history of UTIs. J Urol 1994, 152:345-349.
20. Stapleton A, Hooton T, Fennell C, Roberts P, Stramm W: Effect of secretor status on vaginal and rectal colonization with fimbriated Escherichia coli in women with and without recurrent urinary tract infection. J Infect Dis 1995, 171:717-720.
21. Jefferson R, Burns J: Urological evaluation of adult renal transplant recipients. J Urol 1995, 153:615-618. Most patients being considered for renal transplantation need minimal urologic assessment consisting of a history and physical, urinalysis and culture.
22. Renoult E, Aouragh F, Mayeux D, Hestin D, Lataste A, Hubert J, L'Hermite J, Weber M, Kessler M: Factors influencing early urinary tract infections in kidney transplant recipients. Transplant Proc 1994, 26:2056-2058.
23. Fox B, Sollinger H, Belzer F: A prospective, randomized, double-blind study of trimethoprim-sulfamethoxazole for prophylaxis of infection in renal transplantation: clinical efficacy, absorption of trimethoprimsulfamethoxazole, effects on the microflora, and the cost benefit of prophylaxis. Am J Med 1990, 89:255-274.
24. Tolkoff-Rubin N, Rubin R: The infectious disease problems of the diabetic renal transplant recipient. Infect Dis Clin North Am 1995, 9(1):117-129.
25. Rubin R: Infection in the organ transplant recipient. In Clinical Approach to Infection in the Compromised Host, third edition. Edited by Rubin RH, Young LS. New York, Plenum; 1994:629-705.